Breast Cancer Can Return After Treatment—New Blood Test May Spot It Earlier
Summary
Researchers have developed a new blood test that may detect the return of breast cancer earlier by analyzing small pieces of DNA in the blood called cell-free DNA (cfDNA). This test looks at how DNA is wrapped around proteins, which can show changes linked to cancer coming back, potentially offering a less invasive way to monitor patients.Key Facts
- The new test analyzes cfDNA, tiny DNA fragments floating in the blood, to detect breast cancer recurrence.
- Current methods for detecting cancer return include mammograms, ultrasounds, biopsies, and scans.
- The study used blood samples from 150 breast cancer patients, including those with initial and recurrent cancer.
- Researchers studied nucleosomes, structures where DNA is wrapped around proteins, to find cancer-related changes.
- The blood test can be less invasive than traditional tissue biopsies and may detect recurrence sooner.
- Two specific DNA regions, RERE and SYNPO2, helped distinguish new cancer growth from the original tumor.
- The test uses machine learning, a kind of computer program that finds patterns in data, to improve accuracy.
- Early detection of cancer returning is important because treatment becomes harder after the cancer spreads.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
